Simplify Logo

Full-Time

Engineer / Senior Process Engineer

Tech Ops MSAT

Confirmed live in the last 24 hours

Abata Therapeutics

Abata Therapeutics

11-50 employees

Develops therapies for autoimmune diseases

Hardware
Biotechnology

Senior, Expert

Belmont, MA, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • BS/BA in Chemical, Biological or Biomedical Engineering with 8+ yrs or MSc with 6+ yrs or equivalent combination of education and work experience
  • 2+ years of experience in cell therapy manufacturing
  • Proven experience with process technical transfer, technical operations, and lifecycle management
  • Detail-oriented with excellent problem-solving, technical writing and verbal communication skills
  • Ability to effectively work in multidisciplinary teams, meet deadlines, and prioritize multiple projects
  • Aptitude for working in a self-driven, performance/results-oriented, fast-paced matrix environment
Responsibilities
  • Serve as the technical representative at the contract manufacturing site, offering on-the-floor technical assistance to optimize manufacturing operations (Person-in-Plant).
  • Collaborate with cross-functional teams, including the CDMO joint project team, Abata Process and Analytical Development, Quality Assurance, Quality Control, and Regulatory to ensure the efficient execution of clinical manufacturing operations and the transfer of new assets and process enhancements within agreed timelines to support business objectives.
  • Review GMP-executed manufacturing batch records
  • Support Deviation Management, CAPA, and Change control to ensure timely batch release.
  • Manage the drafting of technical documents, such as master batch records and components of technology transfer packages
  • Function as a manufacturing subject matter expert within the MSAT organization
  • Collect and analyze manufacturing data to identify areas for improvement
  • Develop and deliver training materials to ensure the operational and scientific training of all employees involved with new processes and product introductions.

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Abata stands out in the biotech market by targeting a specific niche of autoimmune disease patients and forming strategic partnerships, such as with ElevateBio, to enhance their research and manufacturing capabilities. The company's goal is to transform treatment options for autoimmune diseases through advanced therapies.

Company Stage

Series A

Total Funding

$60.3M

Headquarters

Cambridge, Massachusetts

Founded

2021

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-5%

2 year growth

11%
Simplify Jobs

Simplify's Take

What believers are saying

  • The appointment of industry veterans like Leonard Dragone and Ellen Cahir-McFarland strengthens Abata's leadership team, enhancing its scientific and clinical capabilities.
  • With significant funding, including a recent $95 million equity investment, Abata is well-positioned to accelerate product development and expand its operations.
  • The company's collaborative and enthusiastic work environment, driven by a mission to transform autoimmune disease treatment, offers a fulfilling and impactful career.

What critics are saying

  • The highly specialized focus on Treg cell therapies may limit Abata's market reach and make it vulnerable to advancements by competitors in broader therapeutic areas.
  • Delays in clinical trials or regulatory approvals could hinder the timely commercialization of their lead product, ABA 201, impacting revenue and growth prospects.

What makes Abata Therapeutics unique

  • Abata Therapeutics leverages the unique biology of regulatory T cells (Tregs) to develop transformative therapies for autoimmune diseases, setting it apart from traditional biotech approaches.
  • Their strategic partnership with ElevateBio ensures scalable and regulatory-compliant manufacturing processes, a critical advantage in the competitive biotech landscape.
  • Focused on niche markets like type 1 diabetes and progressive multiple sclerosis, Abata addresses unmet medical needs with innovative Treg cell therapies.